A spin-off of SRI International, GeneTrace is a Systems Biology company focused on the discovery of new drug leads and drug targets. The Company uses a proprietary, comprehensive and integrated platform of genomic, proteomic and bioinformatic technologies to find drug targets and select lead compounds. March 2000, the firm acquired Strata Biosciences a privately funded functional genomics company pioneering the implementation of proprietary high-throughput gene knockout technologies for gene discovery, drug target identification and validation. Though the firm is listed in several systems, it is not clear if they are still operational
